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Abstract 
Objective: Systemic sclerosis (SS) is a chronic autoimmune disease of connective tissue, which 
involves skin and internal organs, and results in collagen deposition and fibroblasts activation. 
Studies have reported a higher risk of malignancy in patients with progressive systemic sclerosis 
(PSS).The aim of this study is to report a case of tongue squamous cell carcinoma (SCC) in a patient 
with PSS. 
Case: A 46-year-old woman with SS presented to the Department of Oral Medicine of Shahid 
Beheshti University of Medical Sciences Dental School with chief complaint of an ulcer on her 
tongue. During intraoral examination, an asymptomatic ulcer measuring 2.0×1.5 cm was discovered 
on the right lateral border of the tongue. Incisional biopsy under local anesthesia was performed and 
histopathological report confirmed presence of squamous cell carcinoma. After further evaluation, 
surgery was performed, followed by three sessions of brachytherapy and six sessions of 
chemotherapy. After 26 months of follow-up, there was no evidence of recurrence. 
Conclusion: Periodic screening examinations are necessary to discover possible malignancies in 
primary stages in patients with SS. 
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Systemic sclerosis is a rare connective tissue 
disorder involving the skin and internal organs. 
It is characterized by high fibroblastic activation 
and collagen deposition. In a systematic review 
Bonifazi reported the prevalence of scleroderma 
to be between seven to 489 cases per million 
individuals, with geographic location playing an 
important role in disease distribution (1).The 
two common types of SS include progressive 
skin scleroderma with involvement of 
extremities, face, body, kidneys, and other 
internal organs, and limited skin scleroderma 
(2). Systemic sclerosis is caused by damage to 
endothelial cells, with their subsequent 
activation and peri vascular inflammation, 
consisting of different types of inflammatory 
cells. Also, extracellular matrix deposition, 
tissue destruction, and different chemokines and 
cytokines, such as Transforming Growth Factor 
β (TGF- β), are involved in the pathogenesis of 
this disease. Transforming Growth Factor β 
increases cell growth and differentiation, and 
collagen and protein matrix synthesis, which 
results in decreased production of a collagenase 
enzyme named matrix metalloproteinase (3). 
Raynaud’s phenomenon is one of the first signs 
of SS. Increase in skin thickness (scleroderma) is 
one of the hallmarks of SS, which begins from 
hands and spreads proximally to the extremities, 
torso, and face. This condition occurs within the 
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first three to five years of the disease. Other skin 
manifestations include telangiectasias ,hypo- or 
hyper-pigmentation, and calcinosis. After skin 
involvement, alimentary tract involvement is the 
most common feature of SS, which manifests in 
the form of dysphagia. Pulmonary fibrosis, 
kidney and heart involvement and abnormalities 
in autonomic, peripheral, and cranial nerves are 
seen in this condition as well. Oral 
manifestations include microstomia, xerostomia, 
telangiectasias, tongue stiffness, gingival 
recession, and difficulty in speech. Pulmonary 
fibrosis and pulmonary hypertension are among 
the most serious causes of death in more than 
50% of patients suffering from SS (1, 2). 
Management of scleroderma includes treatment 
of vascular complications such as Raynaud’s 
phenomenon, and immunosuppressive therapy, 
which inhibit connective tissue proliferation (3). 
Additionally, multiple studies have reported a 
higher risk of malignancies in patients suffering 
from PSS compared to general population. 
Possible mechanisms include impairment of 
carcinogen clearance, defects in immune system, 
familial susceptibility, and increased 
susceptibility to malignant transformation(4).In 
a cohort study of 769 patients with PSS, Derk, et 
al. (2005) found six cases of SCC of the tongue 
and reported a higher risk of this malignancy in 
these patients (5).There have been case reports 
of SCC of the skin, oesophagus and the lips in 
patients with scleroderma (6-8).The aim of this 
study is to report a rare case of SCC of the 




A 46-year-old female patient presented to the 
Department of Oral Medicine of Shahid 
Beheshti University of Medical Sciences Dental 
School with the chief complaint of an ulcer on 
her tongue over the previous two months. She 
was diagnosed with SS two years prior to 
admission, for which she was on prednisolone, 
colchicine, and azathioprine. In addition, she had 
a history of hypertension, which was controlled 
with captopril. She had no family history of 
cancer among her first-degree relatives. Physical 
examination was significant for multiple 
telangiectasias on her face, stretched lips (fish 
mouth appearance) (Figure 1), limited mouth 
opening, and thickening of her fingers skin.  
 
Figure 1- Multiple telangiectasias on the face and 
stretched lips in our patient with PSS 
 
Oral examination revealed an ulcer measuring 
2.0×1.5 cm in the right lateral border of her 
tongue with rolled borders, but no in duration 
was felt on palpation (Figure 2). 
 
Figure 2- A rolled-border ulcer on the lateral 
border of the tongue in our patient with PSS 
 
Because the ulcer was exclusively in the soft 
tissue, there was no need to request radiographic 
imaging. There was no submandibular or 
cervical lymph node involvement. An incisional 
biopsy was performed under local anesthesia and 
histopathological examination revealed a 
malignant epithelial tumor, composed of islands 
of squamous cells with pleomorphism, keratin 
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pearl formation, hyperchromatism, a few mitotic 
figures, and giant nuclei. Tumor cells in most 
areas were arranged as scattered individual cells 
penetrating deep into the connective tissue. 
Invasion of tumor cells into vessels and bundles 
were also evident and a diagnosis of SCC was 
made (Figure 3). 
 
 
Figure 3a, b- Malignant epithelial tumor, composed of islands of squamous cells with pleomorphism, keratin 
pearl formation, hyperchromatism, a few mitotic figures, and giant nuclei. Tumor cells in most areas were 
arranged as scattered individual cells penetrating deep into the connective tissue. 
 
The patient was referred to the Cancer Institute 
of Tehran University of Medical Sciences for 
further evaluation and treatment. Subsequently, 
the patient underwent surgical resection of the 
tumor. Upon neck dissection, there was evidence 
of perineural, muscular, and lymph node 
involvement. Surgical excision of the lesion was 
followed by three sessions of brachytherapy and 
six courses of chemotherapy (cisplatin and 5-
Fluorouracil).After 26 months of follow-up, 






The association between PSS and malignancies 
has been mentioned in previous studies (5),but 
continues to remain an area of debate. According 
to some studies, the incidence of malignancy 
among patients with SS ranges from 3.6 to 
10.7% with the mean of 6.3 % (4). A case of 
alveolar cell carcinoma was the first report 
linking SS with cancer (9).Despite studies by 
Black, et al.  in 1982 (10) and Chatterjee, et al. 
in 2005 (11), which showed no increased risk of 
cancer in patients with PSS, many other studies 
have shown an increased risk of cancer in these 
patients(4,5,12). Lung cancer is the most 
common malignancy in patients with SS, 
followed by breast cancer, and gastrointestinal 
malignancies (4-5-9). Derk, et al. in 2005 
demonstrated that patients with PSS had a 
25fold higher frequency of tongue carcinoma 
compared to general population. They identified 
nine patients with SCC of the oral cavity and 
pharynx, six of which had SCC of the tongue 
(5). In 2009, Petrov, et al. reported the first case 
of SCC of the tongue in a patient with 
scleroderma (8). The current case report 
confirms prior reports and shows a higher risk of 
malignancy in patients with PSS.  
Factors involved in the pathogenesis of both PSS 
and malignancy are reported to be the same. 
Viral infections and exposure to certain 
chemicals are among these factors. One 
hypothesis about the pathogenesis of oral cancer 
in patients with PSS is exposure of the oral 
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cavity to environmental factors, such as betel 
nut, perchloroethylene, and herbal medicines 
containing aristolochic acid, which can result in 
malignancy and fibrosis (5). 
Malignancy may be seen in patients with both 
limited or diffuse forms of SS. Wooten et al. 
(2008) stated that female sex, the average age of 
58 years old and systemic form of SS increase 
the risk of malignancy (4). In a study by Derk, et 
al. (2005) all patients with scleroderma, which 
had SCC of the tongue, were involved with 
diffuse form of the disease (5). After further 
evaluation, they concluded that SCC of the 
tongue occurred at least one year after diagnosis 
of PSS was made, with the average age of 56.3 
(11.1) years. The case reported by us was similar 
to the previous studies in terms of patient sex 
and diffuse skin involvement. However, our 
patient was diagnosed with another malignancy 
about a decade earlier. Also, she was diagnosed 
with SCC of the tongue two year after being 
diagnosed with SS. 
On the other hand, malignancy in patients 
suffering from PSS may be the result of the 
medications used to treat it (4). 
Immunosuppressant (cyclophosphamide, 
methotrexate, azathioprine) may predispose 
patients to malignancies (13). However, 
according to Hesselstrand (14), there is no such 
a relationship between scleroderma treatment 
and developing cancer. In a study by Derk, et al. 
(2005), half of the patients who had both PSS 
and SCC of the tongue received D-penicillamine 
as the treatment for PSS. Our patient has been 
receiving azathioprine but not D-penicillamine 
(5). 
Despite its rarity, tongue cancer is the second 
most common malignancy of the oral cavity (5). 
Tobacco and heavy alcohol use are two 
exogenous agents that increase the risk of oral 
cancer (15). In the study by Derk, et al. (2005), 
33% of patients had a positive family history of 
cancer and only one patient had an additional 
risk factor such as tobacco and alcohol use (5). 
Our patient had none of these risk factors. She 
did not use to smoke nor drink alcohol, and had 
no family history of cancer. It seems that PSS 
and exposure to immunosuppressant might 
predispose her to oral cancer. Since the majority 
of patients with SS undergo immunosuppressive 
therapy, periodic screening to diagnose 




Given the increased risk of malignancy in 
patients suffering from scleroderma and PSS, 
periodic screening and follow up examination 
are necessary in order to detect possible 
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